<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-16T12:57:17Z</responseDate><request verb="GetRecord" identifier="oai:ebiltegia.mondragon.edu:20.500.11984/1501" metadataPrefix="rdf">https://ebiltegia.mondragon.edu/oai/request</request><GetRecord><record><header><identifier>oai:ebiltegia.mondragon.edu:20.500.11984/1501</identifier><datestamp>2024-03-04T15:18:37Z</datestamp><setSpec>com_20.500.11984_473</setSpec><setSpec>col_20.500.11984_478</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:ebiltegia.mondragon.edu:20.500.11984/1501">
      <dc:title>Dementia related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization</dc:title>
      <dc:creator>Soto-Gordoa, Myriam</dc:creator>
      <dc:contributor>Mar Medina, Javier</dc:contributor>
      <dc:contributor>Arrospide, Arantzazu</dc:contributor>
      <dc:contributor>Iruin, Álvaro</dc:contributor>
      <dc:contributor>Tainta, Mikel</dc:contributor>
      <dc:contributor>Gabilondo, Andrea</dc:contributor>
      <dc:contributor>Mar-Barrutia, Lore</dc:contributor>
      <dc:contributor>Calvo, Montserrat</dc:contributor>
      <dc:contributor>Ibarrondo Olagüenaga, Oliver</dc:contributor>
      <dc:subject>neuropsychiatric symptoms</dc:subject>
      <dc:subject>dementia</dc:subject>
      <dc:subject>antidepressant drugs</dc:subject>
      <dc:subject>antipsychotic drugs</dc:subject>
      <dc:subject>nursing home</dc:subject>
      <dc:subject>inequalities</dc:subject>
      <dc:subject>deprivation index</dc:subject>
      <dc:description>Background: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant&#xd;
of family stress and institutionalization of patients. This study aimed to identify inequalities&#xd;
by gender and socioeconomic status in the management of NPS in patients diagnosed with&#xd;
dementia.&#xd;
Methods: An observational study was carried out to study all the cases of dementia in the&#xd;
corporate database of the Basque Health Service (29,864 patients). The prescription of&#xd;
antipsychotics and antidepressants and admission to a nursing home were used to establish&#xd;
the presence of NPS. The socioeconomic status of individuals was classified by a deprivation&#xd;
index. Logistic regressions were used to identify drivers for drug prescriptions and&#xd;
institutionalization.&#xd;
Results: NPS are poorly recorded in the clinical databases (12%). Neuropsychiatric symptoms&#xd;
were severe enough in two thirds of patients with dementia to be treated with&#xd;
psychoactive medication. Institutionalization showed an increase from those who did not&#xd;
receive medication to those who had been prescribed antidepressants (OR: 1.546), antipsychotics&#xd;
(OR: 2.075) or both (OR: 2.741). The resulting inequalities were the increased&#xd;
prescription of antidepressant drugs in women and more nursing-home admissions for&#xd;
women who were the least socioeconomically deprived and men who were the most&#xd;
deprived.&#xd;
Conclusions: In large clinical databases, psychoactive drugs prescriptions can be useful to&#xd;
underscore the considerable burden of dementia-related NPS. Specific tools are needed to&#xd;
monitor social and health care programs targeted to dementia-related NPS from a population&#xd;
perspective. Programs aimed at reducing the family burden of care of dementia patients at&#xd;
home become the key elements in reducing inequalities in these patients’ care.&#xd;
Socioeconomic status is the most important driver of inequality, and gender inequality may&#xd;
simply be hidden within the social environment. Integrated programs boosting the continuity&#xd;
of care are an objective for which compliance could be measured according to the NPS&#xd;
coding in the electronic health record.</dc:description>
      <dc:date>2019-11-15T16:01:12Z</dc:date>
      <dc:date>2019-11-15T16:01:12Z</dc:date>
      <dc:date>2019</dc:date>
      <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
      <dc:identifier>1178-2021 online</dc:identifier>
      <dc:identifier>1176-6328 print</dc:identifier>
      <dc:identifier>https://katalogoa.mondragon.edu/janium-bin/janium_login_opac.pl?find&amp;ficha_no=153442</dc:identifier>
      <dc:identifier>https://hdl.handle.net/20.500.11984/1501</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>© Dove Medical Press Limited</dc:rights>
      <dc:publisher>Dove Medical Press Limited</dc:publisher>
      <dc:publisher>prevalence</dc:publisher>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>